Ho Chi Minh City, Vietnam, March 2026 — Glenmark Pharmaceuticals has named Philippe Gautron as Senior Vice President & Business Head – APAC, entrusting him with leadership of the company’s operations across the Asia-Pacific region. In this role, Gautron will hold full P&L responsibility for 19 markets, supporting Glenmark’s strategy to strengthen its regional presence and drive growth across APAC.
Gautron joins Glenmark with extensive global leadership experience in the pharmaceutical sector and a strong track record in business transformation, market expansion, and strategic partnerships.
Prior to this appointment, he served as General Manager at STADA Pymepharco, where he was responsible for overall P&L and legal oversight. His role included managing commercial operations, manufacturing facilities, and multiple legal entities. During his tenure, he led significant transformation initiatives, including leadership restructuring, redesigning the go-to-market strategy across retail and medical channels, and strengthening government affairs and compliance frameworks.
Earlier, Gautron spent more than a decade with DKSH, where he held several senior leadership roles, including Head South East Asia-Pacific and Head of Global Business Development – Own Brands. In these roles, he led the Own Brands business across ten Southeast Asia and Pacific markets and played a key role in global business development initiatives, including mergers, acquisitions, and licensing partnerships across multiple regions.
Before joining DKSH, Gautron served as South East Asia Head at Exeltis, part of the CHEMO Group (INSUD Pharma). There, he led pharmaceutical operations across key Southeast Asian markets including Thailand, Vietnam, the Philippines, Indonesia, Malaysia, and Singapore, with full P&L responsibility and leadership for regional expansion.
Earlier in his career, Gautron held country leadership roles with Abbott (Solvay Pharma) and Fournier Pharma, where he managed affiliate operations, drove market development strategies, and built strong commercial teams across Europe and Asia.
With more than two decades of experience in the global pharmaceutical industry, Gautron brings deep expertise in regional leadership, commercial strategy, and business transformation. His appointment underscores Glenmark Pharmaceuticals’ continued focus on strengthening its footprint and accelerating growth across the Asia-Pacific region.
About Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Limited is a research-driven global pharmaceutical company focused on improving lives through innovation. Over the past four decades, the company has evolved from a generics-focused organization into a global pharmaceutical player offering specialty, branded, and over-the-counter products.
Today, Glenmark has a strong presence in more than 80 countries and maintains a diversified portfolio across key therapeutic areas including dermatology, respiratory, and oncology. With ten advanced manufacturing facilities across four continents, the company continues to work toward delivering innovative medicines that improve patient outcomes worldwide.
